List of Tables
Table 1. Gastrointestinal Cancer Treatment Market Trends
Table 2. Gastrointestinal Cancer Treatment Market Drivers & Opportunity
Table 3. Gastrointestinal Cancer Treatment Market Challenges
Table 4. Gastrointestinal Cancer Treatment Market Restraints
Table 5. Global Gastrointestinal Cancer Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Gastrointestinal Cancer Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Gastrointestinal Cancer Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Gastrointestinal Cancer Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Gastrointestinal Cancer Treatment
Table 10. Global Gastrointestinal Cancer Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Gastrointestinal Cancer Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Gastrointestinal Cancer Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Gastrointestinal Cancer Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Gastrointestinal Cancer Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Gastrointestinal Cancer Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Gastrointestinal Cancer Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Gastrointestinal Cancer Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Gastrointestinal Cancer Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Gastrointestinal Cancer Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Gastrointestinal Cancer Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Gastrointestinal Cancer Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Gastrointestinal Cancer Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Gastrointestinal Cancer Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Gastrointestinal Cancer Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Gastrointestinal Cancer Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Gastrointestinal Cancer Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Gastrointestinal Cancer Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Gastrointestinal Cancer Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Eli Lilly Basic Information List
Table 32. Eli Lilly Description and Business Overview
Table 33. Eli Lilly Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Eli Lilly (2019-2024)
Table 35. Eli Lilly Recent Developments
Table 36. F. Hoffmann Basic Information List
Table 37. F. Hoffmann Description and Business Overview
Table 38. F. Hoffmann Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of F. Hoffmann (2019-2024)
Table 40. F. Hoffmann Recent Developments
Table 41. GlaxoSmithKline Basic Information List
Table 42. GlaxoSmithKline Description and Business Overview
Table 43. GlaxoSmithKline Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of GlaxoSmithKline (2019-2024)
Table 45. GlaxoSmithKline Recent Developments
Table 46. Merck Basic Information List
Table 47. Merck Description and Business Overview
Table 48. Merck Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Merck (2019-2024)
Table 50. Merck Recent Developments
Table 51. Novartis AG Basic Information List
Table 52. Novartis AG Description and Business Overview
Table 53. Novartis AG Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Novartis AG (2019-2024)
Table 55. Novartis AG Recent Developments
Table 56. Otsuka Holdings Basic Information List
Table 57. Otsuka Holdings Description and Business Overview
Table 58. Otsuka Holdings Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Otsuka Holdings (2019-2024)
Table 60. Otsuka Holdings Recent Developments
Table 61. Stryker Corporation Basic Information List
Table 62. Stryker Corporation Description and Business Overview
Table 63. Stryker Corporation Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Stryker Corporation (2019-2024)
Table 65. Stryker Corporation Recent Developments
Table 66. Boston Scientific Corporation Basic Information List
Table 67. Boston Scientific Corporation Description and Business Overview
Table 68. Boston Scientific Corporation Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Boston Scientific Corporation (2019-2024)
Table 70. Boston Scientific Corporation Recent Developments
Table 71. Johnson and Johnson Basic Information List
Table 72. Johnson and Johnson Description and Business Overview
Table 73. Johnson and Johnson Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Johnson and Johnson (2019-2024)
Table 75. Johnson and Johnson Recent Developments
Table 76. CONMED Corporation Basic Information List
Table 77. CONMED Corporation Description and Business Overview
Table 78. CONMED Corporation Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of CONMED Corporation (2019-2024)
Table 80. CONMED Corporation Recent Developments
Table 81. Bristol-Myers Squibb Basic Information List
Table 82. Bristol-Myers Squibb Description and Business Overview
Table 83. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Bristol-Myers Squibb (2019-2024)
Table 85. Bristol-Myers Squibb Recent Developments
Table 86. Pfizer Basic Information List
Table 87. Pfizer Description and Business Overview
Table 88. Pfizer Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 89. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Pfizer (2019-2024)
Table 90. Pfizer Recent Developments
Table 91. Celltrion Inc Basic Information List
Table 92. Celltrion Inc Description and Business Overview
Table 93. Celltrion Inc Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 94. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Celltrion Inc (2019-2024)
Table 95. Celltrion Inc Recent Developments
Table 96. Amgen Limited Basic Information List
Table 97. Amgen Limited Description and Business Overview
Table 98. Amgen Limited Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 99. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Amgen Limited (2019-2024)
Table 100. Amgen Limited Recent Developments
Table 101. Celgene Corporation Basic Information List
Table 102. Celgene Corporation Description and Business Overview
Table 103. Celgene Corporation Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 104. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Celgene Corporation (2019-2024)
Table 105. Celgene Corporation Recent Developments
Table 106. Sanofi Basic Information List
Table 107. Sanofi Description and Business Overview
Table 108. Sanofi Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 109. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Sanofi (2019-2024)
Table 110. Sanofi Recent Developments
Table 111. Mylan N.V. Basic Information List
Table 112. Mylan N.V. Description and Business Overview
Table 113. Mylan N.V. Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 114. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Mylan N.V. (2019-2024)
Table 115. Mylan N.V. Recent Developments
Table 116. Samsung Bioepis Basic Information List
Table 117. Samsung Bioepis Description and Business Overview
Table 118. Samsung Bioepis Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 119. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Samsung Bioepis (2019-2024)
Table 120. Samsung Bioepis Recent Developments
Table 121. Teva Pharmaceutical Industries Ltd. Basic Information List
Table 122. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 123. Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Products, Services and Solutions
Table 124. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Teva Pharmaceutical Industries Ltd. (2019-2024)
Table 125. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 126. Key Raw Materials Lists
Table 127. Raw Materials Key Suppliers Lists
Table 128. Gastrointestinal Cancer Treatment Downstream Customers
Table 129. Gastrointestinal Cancer Treatment Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Gastrointestinal Cancer Treatment Product Picture
Figure 2. Global Gastrointestinal Cancer Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Gastrointestinal Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Gastrointestinal Cancer Treatment Report Years Considered
Figure 5. Global Gastrointestinal Cancer Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Gastrointestinal Cancer Treatment Revenue in 2023
Figure 7. Gastrointestinal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Surgery Picture
Figure 9. Targeted Drugs Therapy Picture
Figure 10. Chemo Therapy Picture
Figure 11. Adjuvant Chemotherapy Picture
Figure 12. Radiation Therapy Picture
Figure 13. Global Gastrointestinal Cancer Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Gastrointestinal Cancer Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospitals
Figure 16. Product Picture of Clinics
Figure 17. Product Picture of Research Centers
Figure 18. Product Picture of Others
Figure 19. Global Gastrointestinal Cancer Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Gastrointestinal Cancer Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Gastrointestinal Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Gastrointestinal Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Gastrointestinal Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Gastrointestinal Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Gastrointestinal Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Gastrointestinal Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Gastrointestinal Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Gastrointestinal Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Gastrointestinal Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Gastrointestinal Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Gastrointestinal Cancer Treatment Sales Value (%), (2019-2030)
Figure 32. United States Gastrointestinal Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Gastrointestinal Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Gastrointestinal Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Gastrointestinal Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Gastrointestinal Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Gastrointestinal Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 38. China Gastrointestinal Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Gastrointestinal Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 40. China Gastrointestinal Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Gastrointestinal Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Gastrointestinal Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Gastrointestinal Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Gastrointestinal Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Gastrointestinal Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Gastrointestinal Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Gastrointestinal Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Gastrointestinal Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Gastrointestinal Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 50. India Gastrointestinal Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Gastrointestinal Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 52. India Gastrointestinal Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 53. Gastrointestinal Cancer Treatment Industrial Chain
Figure 54. Gastrointestinal Cancer Treatment Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
